Neil A Klompas - Net Worth and Insider Trading

Neil A Klompas Net Worth

The estimated net worth of Neil A Klompas is at least $219,506 dollars as of 2024-03-01. Neil A Klompas is the President & COO of Zymeworks Inc and owns about 17,732 shares of Zymeworks Inc (ZYME) stock worth over $219,506. Details can be seen in Neil A Klompas's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Neil A Klompas has not made any transactions after 2023-03-10 and currently still holds the listed stock(s).

Transaction Summary of Neil A Klompas

To

Neil A Klompas Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Neil A Klompas owns 1 companies in total, including Zymeworks Inc () .

Click here to see the complete history of Neil A Klompas’s form 4 insider trades.

Insider Ownership Summary of Neil A Klompas

Ticker Comapny Transaction Date Type of Owner
Zymeworks Inc 2023-03-10 President & COO

Neil A Klompas Latest Holdings Summary

Neil A Klompas currently owns a total of 1 stock. Neil A Klompas owns 17,732 shares of Zymeworks Inc (ZYME) as of March 10, 2023, with a value of $219,506.

Latest Holdings of Neil A Klompas

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ZYME Zymeworks Inc 2023-03-10 17,732 12.38 219,506

Holding Weightings of Neil A Klompas


Neil A Klompas Form 4 Trading Tracker

According to the SEC Form 4 filings, Neil A Klompas has made a total of 6 transactions in Zymeworks Inc (ZYME) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Zymeworks Inc is the sale of 2,977 shares on March 10, 2023, which brought Neil A Klompas around $23,310.

Insider Trading History of Neil A Klompas

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Neil A Klompas Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Neil A Klompas Ownership Network

Ownership Network List of Neil A Klompas

No Data

Ownership Network Relation of Neil A Klompas


Neil A Klompas Owned Company Details

What does Zymeworks Inc do?

Who are the key executives at Zymeworks Inc?

Neil A Klompas is the President & COO of Zymeworks Inc. Other key executives at Zymeworks Inc include director & Chair & CEO Kenneth Galbraith , SVP & Chief Financial Officer Christopher Astle , and Chief Scientific Officer Paul Andrew Moore .

Zymeworks Inc () Insider Trades Summary

Over the past 18 months, Neil A Klompas made 1 insider transaction in Zymeworks Inc () with a net sale of 2,977. Other recent insider transactions involving Zymeworks Inc () include a net purchase of 5,868,900 shares made by Ecor1 Capital, Llc , a net sale of 8,654 shares made by Christopher Astle , and a net sale of 7,425 shares made by Neil Josephson .

In summary, during the past 3 months, insiders sold 40,583 shares of Zymeworks Inc () in total and bought 0 shares, with a net sale of 40,583 shares. During the past 18 months, 52,759 shares of Zymeworks Inc () were sold and 5,899,381 shares were bought by its insiders, resulting in a net purchase of 5,846,622 shares.

Zymeworks Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zymeworks Inc Insider Transactions

No Available Data

Neil A Klompas Mailing Address

Above is the net worth, insider trading, and ownership report for Neil A Klompas. You might contact Neil A Klompas via mailing address: 114 East 4th Avenue, Suite 800, Vancouver A1 V5t 1g4.

Discussions on Neil A Klompas

No discussions yet.